Intellia Therapeutics Inc...

NASDAQ: NTLA · Real-Time Price · USD
10.99
0.09 (0.83%)
At close: Aug 15, 2025, 3:59 PM
11.01
0.18%
After-hours: Aug 15, 2025, 07:57 PM EDT

Intellia Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
14.24M 16.63M 12.87M 9.11M 6.96M 28.93M -1.92M 11.99M 13.59M 12.61M 13.57M 13.27M 14.03M 11.25M 12.85M 7.2M 6.55M 6.45M
Cost of Revenue
n/a n/a 2.57M 2.61M 2.6M 2.51M 2.47M 2.29M 2.17M 2.05M 2.03M 96.65M 1.84M 1.75M 1.88M 60.49M 58.88M 39.28M
Gross Profit
14.24M 16.63M 7.7M 9.11M 4.36M 26.42M -4.38M 9.7M 11.42M 10.56M 11.54M -83.39M 12.19M 9.5M 10.97M -53.28M -52.33M -32.83M
Operating Income
-110M -120.81M -136.45M -144.77M -139.04M -114M -139.89M -131.11M -132.33M -111.96M -110.09M -105.53M -98.3M -144.25M -80.42M -71.99M -69.02M -46.42M
Interest Income
7.4M 8.6M 10.63M 12.12M 12.42M 12.63M 12.46M 12.74M 12.65M 11.98M 5.35M 1.95M 703K 540K 503K 349K 211K 220K
Pretax Income
-101.25M -114.33M -128.9M -135.71M -146.97M -107.44M -132.16M -122.22M -123.68M -103.13M -113.41M -113.23M -100.68M -146.87M -81.24M -71.64M -68.81M -46.2M
Net Income
-101.25M -114.33M -128.9M -135.71M -146.97M -107.44M -132.16M -122.22M -123.68M -92.34M -116.73M -113.23M -99.97M -146.87M -81.24M -71.64M -68.81M -46.2M
Selling & General & Admin
27.21M 29.01M 32.44M 30.5M 31.79M 31.09M 28.99M 29.4M 30.65M 27.45M 23.63M 22.14M 22.13M 22.4M 22.11M 18.71M 16.68M 13.59M
Research & Development
97.03M 108.43M 114.31M 123.38M 111.61M 109.33M 108.98M 113.7M 115.28M 97.12M 100.03M 96.65M 90.2M 133.09M 71.16M 60.49M 58.88M 39.28M
Other Expenses
n/a n/a n/a n/a n/a n/a -2.47M -2.29M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
124.24M 137.43M 146.75M 153.88M 143.4M 140.43M 135.51M 140.81M 145.93M 124.56M 123.66M 118.8M 112.33M 155.5M 93.27M 79.2M 75.57M 52.87M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
124.24M 137.43M 149.32M 153.88M 146M 142.94M 137.97M 143.1M 145.93M 124.56M 123.66M 118.8M 112.33M 155.5M 93.27M 79.2M 75.57M 52.87M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -10.78M 3.32M n/a -703K -119K n/a n/a n/a n/a
Shares Outstanding (Basic)
103.73M 103.5M 101.86M 101M 96.97M 95.5M 90.46M 88.64M 88.19M 87.77M 81.22M 76.05M 75.7M 74.75M 74.43M 73.71M 68.16M 67.18M
Shares Outstanding (Diluted)
103.73M 103.5M 101.86M 101M 96.97M 95.5M 90.46M 88.64M 88.19M 87.77M 81.22M 76.05M 75.82M 74.75M 74.43M 73.71M 68.16M 67.18M
EPS (Basic)
-0.98 -1.1 -1.27 -1.34 -1.52 -1.12 -1.46 -1.38 -1.4 -1.05 -1.44 -1.49 -1.32 -1.96 -1.09 -0.97 -1.01 -0.69
EPS (Diluted)
-0.98 -1.1 -1.27 -1.34 -1.52 -1.12 -1.46 -1.38 -1.4 -1.05 -1.44 -1.49 -1.32 -1.96 -1.09 -0.97 -1.01 -0.69
EBITDA
-107.52M -118.31M -133.88M -142.16M -136.44M -111.49M -137.43M -128.82M -130.16M -109.91M -108.06M -103.58M -96.46M -142.49M -78.53M -70.21M -67.38M -44.83M
EBIT
-110M -120.81M -136.45M -144.77M -139.04M -114M -139.89M -131.11M -132.33M -111.96M -110.09M -105.53M -98.3M -144.25M -80.42M -71.99M -69.02M -46.42M
Depreciation & Amortization
2.47M 2.5M 2.57M 2.61M 2.6M 2.51M 2.47M 2.29M 2.17M 2.05M 2.03M 1.95M 1.84M 1.75M 1.88M 1.79M 1.63M 1.59M